Coming soon to a town near you…October 17, 2018 is recreational cannabis legalization in Canada. Who knew this day was going to come? Canada is poised to become a leader by being the first G7 nation to legalize cannabis for recreational purposes. This has led to much excitement and trepidation among Canadians as this industry is shaping itself while the world is watching this experiment play out. With a sophisticated black market, a host of regulatory controls, and a lack of choice – what will Canadian cannabis legalization look like?
We are happy to share our Co-Founder, Krystal Laferriere, has been named Lyfebulb Ambassador for patients with chronic illness. Lyfebulb is a non-profit, patient-centric organization whose mission is to improve the quality of life for people living with chronic disease.
"Lyfebulb Ambassadors are leaders in the community. They are advocates, and passionate individuals who use their voice to tell stories, create change, and inspire others living with chronic disease."
Krystal's goal is to empower others to be an advocate for their own health and wellness and share in her journey dealing with Crohn's Disease. She aims to educate on the benefits that cannabis products can offer as an add-on to traditional therapies for IBD.
"Looking to add to its product lineup, Calgary-based health and wellness company Kanabé Corp. has penned a letter of intent to utilize the assets of Abattis Bioceuticals Corp. (CSE:ATT) (OTC:ATTBF).
Shareholders are apparently liking the news, carrying shares of ATT up four cents, or 12.7%, to 35.5 cents as of 2:30 p.m. in Toronto March 8, 2018."
See the full article here: